Morphological Characteristic of Melanoma B16 Progression in C57BL/6 Mice with High and Low Resistance to Hypoxia

[1]  E. Unger,et al.  Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment , 2018, International journal of nanomedicine.

[2]  E. Swenson,et al.  High Altitude and Cancer Mortality. , 2018, High altitude medicine & biology.

[3]  Н. А. Лыжко Молекулярно-генетические механизмы инициации, промоции и прогрессии опухолей , 2017 .

[4]  E. Cicinelli,et al.  Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer , 2017, International journal of molecular sciences.

[5]  U. Flögel,et al.  Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice , 2014, BMC Cancer.

[6]  D. Navajas,et al.  Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea , 2013, Respiratory Physiology & Neurobiology.

[7]  E. Gershtein,et al.  Vascular Endothelial Growth Factor and Type 2 Receptor for This Factor in Vascular Malformations , 2011, Bulletin of Experimental Biology and Medicine.

[8]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[9]  G. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.

[10]  P. Vaupel,et al.  Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.

[11]  G. Nicolson,et al.  Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. , 1976, Journal of the National Cancer Institute.

[12]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.